Company Profile
Stereotaxis Stock Price, News & Catalysts
- Ticker:
- STXS
- Exchange:
- AMEX
- Sector:
- Biopharma
- Location:
- United States
Stock performance
1.29 USD (-2.27%)
Close
Last updated: September 17, 2026
193M USD
Market cap
Why the stock is moving
The latest monitored headline was “Stereotaxis Emerging Digital, AI and Automation Capabilities to be Featured at Heart Rhythm Society’s HRX 2026”. STXS was little changed in the corresponding trading session, closing at $1.32 on Sep 16, 2026.
Company overview
Endovascular Surgical Robotics
Stereotaxis develops robotic systems, instruments, and software for minimally invasive endovascular procedures.
Magnetic Navigation
Its robotic magnetic navigation platform allows physicians to steer compatible catheters through the heart with precise remote control.
Integrated Procedure Suite
The MAGiC robotically navigated catheter and Synchrony digital operating-room system extend Stereotaxis from capital equipment into proprietary instruments and workflow software.
Broader Robotics Strategy
The planned Robocath acquisition would combine complementary robotic technologies across cardiac and vascular intervention.
Future catalysts
- Stereotaxis’s catalysts are robotic catheter adoption, system placements, and growth in electrophysiology workflow. The market will care about whether the technology can keep winning procedure share.
Recent news
- 01
- 02
- 03
- 04
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Stereotaxis (STXS)?
Stereotaxis (STXS) most recently closed at 1.29 USD, a -2.27% move versus the previous session.
What is the market cap of Stereotaxis (STXS)?
Stereotaxis currently has a market capitalization of 193M USD on BioPharmSignal.
What does Stereotaxis do?
Endovascular Surgical Robotics Stereotaxis develops robotic systems, instruments, and software for minimally invasive endovascular procedures. Magnetic Navigation Its robotic magnetic navigation platform allows physicians to steer compatible catheters through the heart with precise remote control. Integrated Procedure Suite The MAGiC robotically navigated...
On which exchange is STXS stock listed?
Stereotaxis (STXS) is associated with AMEX, United States, Biopharma.
What is Endovascular?
Endovascular Surgical Robotics Stereotaxis develops robotic systems, instruments, and software for minimally invasive endovascular procedures.
Which conditions is Stereotaxis targeting with Endovascular?
Endovascular Surgical Robotics Stereotaxis develops robotic systems, instruments, and software for minimally invasive endovascular procedures. Magnetic Navigation Its robotic magnetic navigation platform allows physicians to steer compatible catheters through the heart with precise remote control. Integrated Procedure Suite The MAGiC robotically navigated...
How does Stereotaxis describe recent progress with Endovascular?
Stereotaxis’s catalysts are robotic catheter adoption, system placements, and growth in electrophysiology workflow. The market will care about whether the technology can keep winning procedure share.
What is Surgical?
Endovascular Surgical Robotics Stereotaxis develops robotic systems, instruments, and software for minimally invasive endovascular procedures.